{{Rsnum
|rsid=11556505
|Gene=TOMM40
|Chromosome=19
|position=44892887
|Orientation=plus
|GMAF=0.1267
|Gene_s=TOMM40
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 84.6 | 15.4 | 0.0
| JPT | 73.2 | 24.4 | 2.4
| YRI | 82.5 | 14.0 | 3.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 84.6 | 15.4 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23288655
|Title=Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population
}}{{PMID Auto
|PMID=17434289
|Title=Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.
|OA=1
}}

{{PMID Auto
|PMID=19668339
|Title=Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=23207651
|Title=A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.
}}